rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas Jensen

CEO

Company insider

Files Form 4 as: CEO, Allarity Therapeutics.

In numbers

Trades disclosed
3
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
22 Jan 2025
Last trade
28 Jan 2026
Last filed
14 May 2026

Companies traded

Where they are an officer
ALLR Allarity TherapeuticsOfficer · Biotechnology · last 28 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Jan 2026filed 14 May 2026ALLR Allarity TherapeuticsBiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
28 Jan 2026filed 14 May 2026ALLR Allarity TherapeuticsBiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
22 Jan 2025filed 24 Jan 2025ALLR Allarity TherapeuticsBiotechnologySEC FORM 4 Code A—396,734 at $0.00filing

News

New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround ...pr-inside.com · 5 Oct 2026

1 headline in the last 90 days name Thomas Jensen; no company of theirs resolves to a name we track.

Sectors

No trade we could place in a sector.

Related people

Jeremy R. GraffOfficer · Officer at Allarity Therapeutics, filing Form 4 there in the last year
Jesper HoeilandDirector · Director at Allarity Therapeutics, filing Form 4 there in the last year
Gerald W. McLaughlinDirector · Director at Allarity Therapeutics, filing Form 4 there in the last year
Jeffrey S. ErvinCFO · CFO at Allarity Therapeutics, filing Form 4 there in the last year